ProCE Banner Activity

Current and Future Role of Radium-223 and PSMA-Targeting Treatment

Slideset

Download these slides from a live symposium to learn more about the use of PSMA-targeted therapy for patients with prostate cancer.

Released: June 02, 2023

Share

Faculty

Karim Fizazi

Karim Fizazi, MD, PhD

Full Professor
Cancer Medicine
Gustave Roussey
Villejuif, France

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck Sharp & Dohme Corp., and Novartis Pharmaceuticals Corporation.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation